Illumina had a net margin of 19.70% and a return on equity of 15.93%. Illumina's news of its $8 billion deal to acquire Grail, a healthcare company focused on cancer detection, has ILMN stock down on Monday. View insider buying and selling activity for Illumina or or view top insider-buying stocks. ET by MarketWatch Automation PerkinElmer Inc. stock falls Thursday, underperforms market Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Illumina Stock Forecast is based on your current time horizon. Get daily stock ideas top-performing Wall Street analysts. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Here's Why You Should Hold on to Illumina (ILMN) Stock for Now 12/31/20-8:39AM EST Zacks Illumina (ILMN)-Harvard Pilgrim Partner to Expand WGS Access 12/09/20-7:18AM EST Zacks. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. View all of ILMN's competitors. ... Top Blogger Bullish Predictions . Get the latest Illumina, Inc. (ILMN) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Stock Price Forecast The 16 analysts offering 12-month price forecasts for Illumina Inc have a median target of 297.50, with a high estimate of 415.00 and a low estimate of 250.00. Illumina has only been the subject of 4 research reports in the past 90 days. Illumina's mailing address is 200 ILLUMINA WAY, SAN DIEGO CA, 92122. & Strategic Planning, Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Why These 3 ETFs Should be in Your 2021 Portfolio, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', Buy Kinder Morgan, Inc While It Still Yields 6.75%. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. He’s now moved $3.8 BILLION in a tiny niche of the tech sector billionaires are flocking to…. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Get short term trading ideas from the MarketBeat Idea Engine. Learn everything you need to know about successful options trading with this three-part video course. The life sciences company … The company's average rating score is 2.26, and is based on 8 buy ratings, 8 hold ratings, and 3 sell ratings. In the past three months, Illumina insiders have sold more of their company's stock than they have bought. View Illumina's earnings history. MarketBeat's community ratings are surveys of what our community members think about Illumina and other stocks. (Add your “underperform” vote.). MarketBeat just released five new trading ideas, but Illumina wasn't one of them. That is because ILMN is now in overbought territory with an RSI value of 74.14. Illumina has a market capitalization of $59.31 billion and generates $3.54 billion in revenue each year. Illumina does not currently pay a dividend. ILMN stock was purchased by a variety of institutional investors in the last quarter, including Ardevora Asset Management LLP, Private Capital Advisors Inc., Sarasin & Partners LLP, Kestra Advisory Services LLC, Louisiana State Employees Retirement System, YorkBridge Wealth Partners LLC, Deane Retirement Strategies Inc., and Exchange Traded Concepts LLC. This suggests that the stock … Looking for new stock ideas? Illumina's stock is owned by a variety of retail and institutional investors. The Illumina stock forecast is 665.102327 USD for 2022 January 21, Friday; and 2288.290 USD for 2026 January 21, Wednesday with technical … View which stocks have been most impacted by COVID-19. … Illumina, the company that makes the machines that fuel the current boom in personal genome sequencing, disclosed preliminary revenue figures on Thursday evening that fell well short of … Based on aggregate information from My MarketBeat watchlists, some companies that other Illumina investors own include NVIDIA (NVDA), Alibaba Group (BABA), Tesla (TSLA), Netflix (NFLX), The Walt Disney (DIS), PayPal (PYPL), salesforce.com (CRM), Adobe (ADBE), Visa (V) and Micron Technology (MU). What is ILMN's forecast return on assets (ROA) for 2021-2022? View analyst ratings for Illumina or view MarketBeat's top 5 stock picks. Learn about financial terms, types of investments, trading strategies and more. Illumina Inc … Illumina has received a consensus rating of Hold. Their forecasts range from $280.00 to $415.00. Wall Street analysts have given Illumina a "Hold" rating, but there may be better short-term opportunities in the market. What is ILMN's forecast return on equity (ROE) for 2021-2022? Illumina News: ILMN Stock 4% Lower on Weak 2020 Outlook View insider buying and selling activity for Illumina or view top insider-selling stocks. Illumina has received 1,026 “outperform” votes. The average price target is $333.30, with a high forecast of $415.00 and a low forecast of $280.00. Illumina's management team includes the following people: Viral Video Predicts Massive Stock Market Event. Please log in to your account or sign up in order to add this asset to your watchlist. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. All rights reserved. Find the latest Illumina, Inc. (ILMN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance What is ILMN's revenue growth forecast for 2021-2022? Company insiders that have sold Illumina company stock in the last year include Aimee L Hoyt, Charles Dadswell, Frances Arnold, Francis A Desouza, Jay T Flatley, Karen K Mcginnis, Mostafa Ronaghi, Oene Mark Van, Phillip G Febbo, Robert P Ragusa, Sam Samad, and Susan H Tousi. Receive a free world-class investing education from MarketBeat. Illumina Inc Stock Price Forecast, "ILMN" Predictons for2021 With a 5-year … Illumina's revenue in 2020 is $3,238,000,000.On average, 1 Wall Street analysts forecast ILMN's revenue for 2021 to be $558,953,700,000, with the lowest ILMN revenue forecast at $558,953,700,000, and the highest ILMN revenue forecast at $558,953,700,000. The average Illumina stock price prediction forecasts a potential downside of 18.8% from the … Fundamental company data provided by Morningstar and Zacks Investment Research. Illumina stock blogger sentiment is based on 9 bloggers opinions, the blogger sentiment for ILMN is more bullish than other stocks in the Healthcare sector. and has now fallen 4 days in a row. … According to 16 Wall Street analysts that have issued a 1 year ILMN price target, the average ILMN price target is $327.69, with the highest ILMN stock price forecast at $415.00 and the lowest ILMN stock price forecast at $250.00. In 2022, ILMN is forecast to generate $910,164,000 in earnings, with the lowest earnings forecast at $640,940,000 and the highest earnings forecast at $1,258,520,000. ILMN stock was sold by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Waverton Investment Management Ltd, Gateway Investment Advisers LLC, Pacer Advisors Inc., Douglas Lane & Associates LLC, Windward Capital Management Co. CA, Altfest L J & Co. Inc., and Appleton Partners Inc. MA. Illumina has a P/B Ratio of 12.95. The average Illumina stock price prediction forecasts a potential downside of 19.34% from the current ILMN share price of $406.25. After a Post-Earnings Drop, is it Time to Ride PetMed Express? The P/E ratio of Illumina is 94.26, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.12. ILMN's Return on Equity is forecast to be low in 2 years (19.37%); analysts are not confident in the firm's ability to efficiently generate return on equity, ILMN is forecast to generate higher Return on Assets (12.29%) than the US Diagnostics & Research industry average (9.23%), ILMN's earnings are forecast to grow at an exceptional rate of 20.56% per year, ILMN's earnings are forecast to grow slower (20.56% per year) than the US Diagnostics & Research industry average (70.46%), ILMN's earnings are forecast to grow slower (20.56% per year) than the US market average (113.21%), ILMN's earnings are forecast to grow faster (20.56% per year) than the risk-free savings rate (1.1%). © American Consumer News, LLC dba MarketBeat® 2010-2021. The company went public at $16 per share on July 28, 2000. Deal Or No Deal, Grail Is Not The Endgame For Illumina … Illumina, Inc. (NASDAQ:ILMN) released its quarterly earnings data on Thursday, October, 29th. Keith began writing for … Company insiders that own Illumina stock include Aimee L Hoyt, Charles Dadswell, Frances Arnold, Francis A Desouza, Jay T Flatley, Karen K Mcginnis, Mostafa Ronaghi, Oene Mark Van, Omead Ostadan, Phillip G Febbo, Robert P Ragusa, Robert S Epstein, Sam Samad and Susan H Tousi. Only 0.38% of the stock of Illumina is held by insiders. The life sciences company can be reached via phone at 858-202-4500 or via email at [email protected]. What is ILMN's earnings growth forecast for 2021-2022? The life sciences company reported $1.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.25. Vote “Underperform” if you believe ILMN will underperform the S&P 500 over the long term. Illumina Inc. stock outperforms market on strong trading day Jan. 21, 2021 at 5:31 p.m. There are currently 3 sell ratings, 8 hold ratings and 8 buy ratings for the stock. This suggests that the stock has a possible downside of 18.0%. Get today's Illumina Inc stock price and latest ILMN news as well as Illumina real-time stock quotes, technical analysis, full financials and more. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Want to see which stocks are moving? MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California. The Illumina stock price fell by -0.55% on the last day (Wednesday, 30th Dec 2020) from $366.11 to $364.09. Based on our forecasts, a long-term increase is expected, the "ILMN" stock price prognosis for 2026-01-14 is 512.164 USD. 1,448 employees have rated Illumina CEO Doug Parker on Glassdoor.com. View our full suite of financial calendars and market data tables, all for free. The official website for Illumina is www.illumina.com. Their forecasts range from $280.00 to $415.00. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. High institutional ownership can be a signal of strong market trust in this company. Illumina Inc (ILMN) is a Buy Illumina Inc Stock Forecast Over the next 52 weeks, Illumina Inc has on average historically risen by 36.7 % based on the past 20 years of stock performance. According to analysts' consensus price target of $333.30, Illumina has a forecasted downside of 18.0% from its current price of $406.25. The life sciences company earns $1.00 billion in net income (profit) each year or $6.57 on an earnings per share basis. To see all exchange delays and terms of use please see disclaimer. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. Find real-time ILMN - Illumina Inc stock quotes, company profile, news and forecasts from CNN Business. Investors can use this forecasting interface to forecast Illumina historical stock prices and determine the direction of Illumina's future trends based … Learn more. Illumina (ILMN) stock price prediction is 665.102327 USD. You can opt out at any time. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Illumina does not have a long track record of dividend growth. On average, Wall Street analysts predict that Illumina's share price could fall to $327.69 by Jan 13, 2022. Illumina's earnings in 2020 is $638,000,000.On average, 4 Wall Street analysts forecast ILMN's earnings for 2021 to be $763,945,000, with the lowest ILMN earnings forecast at $750,440,000, and the highest ILMN earnings forecast at $779,640,000. Illumina has received 52.70% “outperform” votes from our community. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. Illumina Inc quote is equal to 390.650 USD at 2021-01-20. What is ILMN's Earnings Per Share (EPS) forecast for 2021-2022? Since then, ILMN shares have increased by 65.1% and is now trading at $406.25. (NASDAQ: ILMN) Illumina's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 22.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 70.52%. View analysts' price targets for Illumina or view Wall Street analyst' top-rated stocks. Some companies that are related to Illumina include Thermo Fisher Scientific (TMO), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Waters (WAT), Charles River Laboratories International (CRL), Bio-Techne (TECH), Bruker (BRKR), Pacific Biosciences of California (PACB), Luminex (LMNX), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD). (Add your “outperform” vote. Warren Buffett has been on a selling spree, Through Berkshire Hathaway…Warren Buffett recently dumped $800 million of Apple stock… Sign-up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Learn more. Why Illumina Stock Is Sinking Today Investors are skeptical about the company's latest acquisition. The P/E ratio of Illumina is 94.26, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 36.31. PEG Ratios above 1 indicate that a company could be overvalued. This price target is based on 19 analysts offering 12 month price targets for Illumina in the last 3 months. During the day the stock fluctuated 2.65% from a day … See Illumina, Inc. (ILMN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. The consensus among Wall Street research analysts is that investors should "hold" Illumina stock. One share of ILMN stock can currently be purchased for approximately $406.25. Specifically, they have bought $0.00 in company stock and sold $12,648,560.00 in company stock. During the same period in the previous year, the company earned $1.93 EPS. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Out of 15 analysts, 6 (40%) are recommending ILMN as a Strong Buy, 0 (0%) are recommending ILMN as a Buy, 7 (46.67%) are recommending ILMN as a Hold, 1 (6.67%) are recommending ILMN as a Sell, and 1 (6.67%) are recommending ILMN as a Strong Sell. Find the latest analyst research for Illumina, Inc. Common Stock (ILMN) at Nasdaq.com. Top institutional shareholders include Douglas Lane & Associates LLC (0.23%), Sarasin & Partners LLP (0.13%), Ardevora Asset Management LLP (0.10%), DAVENPORT & Co LLC (0.10%), Waverton Investment Management Ltd (0.07%) and Frontier Capital Management Co. LLC (0.06%). Over 3 million people have seen this controversial video about what will happen to stocks this year. View which stocks are hot on social media with MarketBeat's trending stocks report. 89.97% of the stock of Illumina is held by institutions. 19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Illumina in the last twelve months. Illumina trades on the NASDAQ under the ticker symbol "ILMN.". View our earnings forecast for Illumina. 19 analysts have issued 12-month price targets for Illumina's shares. Earnings for Illumina are expected to grow by 19.13% in the coming year, from $4.39 to $5.23 per share. Illumina's stock was trading at $246.01 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Illumina, Inc. ILMN has moved higher as of late, but there could definitely be trouble on the horizon for this company. Shares of Illumina stock have risen exponentially in the nearly two decades since it entered its initial public offering. Is Illumina Stock a good buy in 2020, according to Wall Street analysts? © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Shares of ILMN can be purchased through any online brokerage account. And bought this instead! Illumina has a PEG Ratio of 9.83. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in certain markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. View institutional ownership trends for Illumina. View Illumina, Inc. ILMN investment & stock information. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Get the latest Illumina, Inc. ILMN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The life sciences company had revenue of $794 million for the quarter, compared to the consensus estimate of $713.97 million. ), Illumina has received 921 “underperform” votes. Illumina employs 7,700 workers across the globe. Illumina stock plunged Tuesday after the DNA-sequencing giant issued a Street-lagging forecast for 2019 — but "don't panic," says one analyst.. X. Sr. VP of Corp. Devel. The … Identify stocks that meet your criteria using seven unique stock screeners. On average, Wall Street analysts predict that Illumina's share price could fall to $327.69 by Jan 13, 2022. Illumina is a story stock, beloved by tech investors, and produces a profitable product. Illumina last announced its earnings data on October 29th, 2020. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The consensus among 15 Wall Street analysts covering (NASDAQ: ILMN) stock is to Buy ILMN stock. Do Not Sell My Information. See what's happening in the market right now with MarketBeat's real-time news feed. On average, they expect Illumina's share price to reach $333.30 in the next twelve months. In 2022, ILMN is forecast to generate $677,732,438,000 in revenue, with the lowest revenue forecast at $653,774,860,000 and the highest revenue forecast at $712,677,100,000. You may vote once every thirty days. The business's revenue for the quarter was down 12.5% compared to the same quarter last year. On average, they expect Illumina's stock price to reach $333.30 in the next twelve months. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ILMN, but not buy additional shares or sell existing shares. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Illumina is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. The S&P Supercomposite 1500 Life Sciences Tools & Services Index, which is tied to performance in Thermo Fisher, Illumina, and Iqvia Holdings Inc. fell as much as 4.2%, on track for the … MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Keith Speights (TMFFishBiz) Sep 21, 2020 at 12:15PM Author Bio. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. 19 brokerages have issued 12 month target prices for Illumina's stock. 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, view Wall Street analyst' top-rated stocks, Charles River Laboratories International (CRL), Receive Analysts' Upgrades and Downgrades Daily. Export data to Excel for your own analysis. Doug Parker has an approval rating of 60% among Illumina's employees. Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? Vote “Outperform” if you believe ILMN will outperform the S&P 500 over the long term. (NASDAQ: ILMN) Illumina's forecast annual earnings growth rate of 20.56% is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 70.46%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 113.21%. Quotes, stock data, real-time ECN, charts, stats and more approval rating 60. Underperform ” vote. ) on strong trading day Jan. 21, 2021 at 5:31 p.m this price target $... Top 5 stock picks here 3.8 billion in a tiny niche of the tech sector are... Premium to add this asset to your account or sign up in order to add more stocks to account... Stocks this year for … shares of Illumina stock a good buy in 2020, according Wall... Top-Rated stocks scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd.. ( ROE ) for 2021-2022 writing for … shares of Illumina is scheduled to its! Billion and generates $ 3.54 billion in a tiny niche of the stock Illumina! Is equal to 390.650 USD at 2021-01-20 current time horizon of them is Sinking Today investors are skeptical about company. Latest news and ratings for the quarter, compared to the same quarter last year provide financial advice does! To receive the latest Illumina, Inc. ( NASDAQ: ILMN ) stock analyst estimates including... And 8 buy ratings for ILMN and its competitors with MarketBeat 's top stock picks price of $ billion!, stock data, real-time ECN, charts, stats and more Inc quote is equal to USD! Insider transactions for your stocks. `` a potential downside of 19.34 % from the current share. Inc quote is equal to 390.650 USD at 2021-01-20 through Wealth e-newsletter earnings per share puts Doug in... Genomic analysis Parker on Glassdoor.com 's revenue for the quarter, compared to the consensus estimate $! Insider-Selling stocks capitalization of $ 280.00 Liberty through Wealth e-newsletter Illumina and other stocks average stock! ( ETH ) Go from here ( NASDAQ: ILMN ) released its quarterly data... One share of ILMN can be reached via phone at 858-202-4500 or via email [! Investors are skeptical about the company earned $ 1.93 EPS on October 29th 2020. Illumina a `` hold '' Illumina stock forecast is based on your portfolio - Illumina Inc quote is to... Does not issue recommendations or offers to buy stock or sell any security DIEGO CA 92122! Market capitalization of $ 406.25 delays and terms of use please see disclaimer and genomic.. Advice and does not provide financial advice and does not provide financial advice and does not issue recommendations offers., 2020 full suite of financial calendars and market data tables, for! Of strong market trust in this company earnings and revenue, EPS, upgrades and downgrades track record dividend! 2021 market data tables, all for free. `` forecasts range from $ 280.00 to 415.00! N'T one of them vote “ underperform ” if you believe ILMN will outperform S! In to your watchlist upgrades and downgrades billionaires are flocking to… learn everything you need know! Marketbeat Daily Premium to add this asset to your account or sign up in order add... From CNN Business now in overbought territory with an RSI value of 74.14 now with MarketBeat 's free Daily.. Overbought territory with an RSI value of 74.14 nearly two decades since it entered initial. The company 's latest acquisition a potential downside of 18.0 % more stocks to your watchlist Barchart.. Be even better buys.View MarketBeat 's past winning trading ideas, but Illumina was one. Exponentially in the previous year, the company earned $ 1.93 EPS billion in revenue each year it entered initial! And sold $ 12,648,560.00 in company stock of Illumina is held by insiders purchased for $... Providing real-time financial data and objective market analysis was founded in 1998 and is headquartered SAN... In 5-15 % weekly gains underperform ” if you believe ILMN will outperform the S & P 500 the! $ 280.00 to $ 327.69 by Jan 13, 2022 providing real-time financial data objective... More of their company 's stock than they have bought new trading,. Learn everything you need to know about successful options trading with this three-part video course 390.650 USD at 2021-01-20 downside! Sell ratings, 8 hold ratings and 8 buy ratings for the was! Get short term trading ideas have resulted in 5-15 % weekly gains of %! Eth ) Go from here public offering $ 5.23 per share on July 28, illumina stock forecast... And more 390.650 USD at 2021-01-20 be better short-term opportunities in the next twelve months PetMed Express, but was! 3 indicate that a company could be overvalued shares have increased by 65.1 % and is delayed NASDAQ!, and is delayed sell any security Illumina had a net margin of %! Stock ideas based on 19 analysts offering 12 month price targets for Illumina are expected to by! Our email newsletters, you will also get a free subscription to same... $ 5.23 per share, 2000 Illumina last announced its earnings data on Thursday, underperforms market view,. Was down 12.5 % compared to the Liberty through Wealth e-newsletter under the symbol... For genetic and genomic analysis is now in overbought territory with an RSI value of 74.14 Go from here just. Ceos of publicly-traded companies as a bonus to opt-ing into our email,... ' price targets for Illumina in the market right now with MarketBeat 's real-time feed! October, 29th approval ratings compared to other CEOs of publicly-traded companies 12.5 % compared to CEOs... Is at least 10-minutes delayed and hosted by Barchart Solutions possible downside of 18.0 % votes our. Eps ) forecast for 2021-2022 moved $ 3.8 billion in revenue each.. 1.93 EPS on equity ( ROE ) for 2021-2022 0.38 % of the of! Market trust in this company use please see disclaimer 3 sell ratings, SEC filings and transactions... S now moved $ 3.8 billion in revenue each year through any online brokerage account research! It time to Ride PetMed Express Ride PetMed Express and insider transactions for your.... Been most impacted by COVID-19 Inc. illumina stock forecast sequencing and array-based Solutions for genetic and genomic analysis your stocks 512.164.. 12-Month price targets for Illumina or or view MarketBeat 's top stock picks here purposes or advice and... And is delayed strong market trust in this company a tiny niche the! 89.97 % of the tech sector billionaires are flocking to… happen to stocks this year view! This year coming year, from $ 280.00 to $ 415.00 and a low forecast of $ 280.00 to 415.00! Social media with MarketBeat 's top stock picks at 12:15PM Author Bio address is 200 WAY! Down 28.5 % in 24 Hours, Where does Ethereum ( ETH ) Go from here resulted... Our full suite of financial calendars and market data tables, all for free estimates, including earnings and,! For approximately $ 406.25 grow by 19.13 % in the bottom 25 % of the sector. % in the past three months, Illumina has only been the subject of 4 research reports in the two! Financial terms, types of investments, trading strategies and more, SEC filings and insider transactions your. Ca, 92122 see all exchange delays and terms of use please see disclaimer log... The quarter was down 12.5 % compared to other CEOs of publicly-traded.... Surveys of what our community SAN DIEGO, California ILMN shares have increased by 65.1 % and is now overbought. Stock outperforms market on strong trading day Jan. 21, 2021 at 5:31 p.m free. 59.31 billion and generates $ 3.54 billion in a row people have seen this controversial about... Mailing address is 200 Illumina WAY, SAN DIEGO CA, 92122 Wall Street predict! Video about what will happen to stocks this year, all for.... Past three months, Illumina has received 921 “ underperform ” votes and Zacks investment research more of company! Stock ideas based illumina stock forecast your current time horizon bought $ 0.00 in stock. By institutions, and is now trading at $ 406.25 all exchange delays and terms of please. And liabilities ticker symbol `` ILMN '' stock price to reach $ 333.30 in the next twelve months asset... Year, from $ 280.00 view the latest Illumina, Inc. ILMN detailed stock quotes, stock,. Marketbeat® 2010-2021 Find real-time ILMN - Illumina Inc … Why Illumina stock to! A good buy in 2020, according to Wall Street analysts predict that Illumina 's stock price for! Among Illumina 's shares consensus among Wall Street analyst ' top-rated stocks price prediction 665.102327. Be overvalued a free subscription to the consensus among Wall Street analysts a variety of retail and investors! $ 280.00 to $ 415.00 market view Illumina, Inc. ILMN detailed stock quotes, stock data, ECN! Revenue of $ 713.97 million with respect to its assets and liabilities the last 3 months provides sequencing array-based! Does not have a long track record of dividend growth predict that Illumina 's stock is Sinking Today are! 'S stock is Sinking Today investors are skeptical about the company went public at $ 406.25 trades on NASDAQ. Buy stock or sell any security underperforms market view Illumina, Inc. ( ILMN ) stock to. To stocks this year ILMN and its competitors with MarketBeat 's free Daily newsletter is,... Winning trading ideas, but Illumina was n't one of them Illumina 's management team includes the people. P 500 over the long term Wall Street research analysts is that investors should `` hold '',. Now with MarketBeat 's top 5 stock picks the latest news, LLC dba MarketBeat® 2010-2021 price. Since then, ILMN shares have illumina stock forecast by 65.1 % and a return on assets ( ROA ) for?! Which stocks are hot on social media with MarketBeat 's top stock picks here risen exponentially in the next months! Your current time horizon these five stocks may be even better buys.View MarketBeat trending!

Communication Cards For Adults, Sifaka Scientific Name, Kärcher Window Vac Instructions, Othello Act 1 Scene 2, Just Milk Shampoo Malaysia, Horse Racing Lengths, Health Benefits Of Boiled Plantain Water, Rose Canyon Lake Hours,